RxDoctor Payments Data

Thomas Smirniotopoulos

Pulmonary Disease · Alexandria, VANPI 1902979727

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.1% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for pulmonary disease clinicians in VA, where the typical reported total is $1,962.

$2,017in general payments, 2019–2025

Across 111 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$475
  • AstraZeneca$297
  • Boehringer Ingelheim$238
  • Insmed, Inc.$177
  • Actelion Pharmaceuticals US, Inc.$144
  • Mylan Specialty L.p.$137
  • plus $549 from 11 others

What the payments were for

  • Food & beverage$1,91895%
  • Education$995%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,017 in reported general payments places this provider in the 50th percentile of 317 pulmonary disease providers in Virginia.

See all pulmonary disease providers in Virginia →

Other pulmonary disease in Alexandria

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →